Search PubMed⌕ Search

PubMed · 6111843

[Bromocriptine therapy].

Abstract

1. The study of bromocriptine and its effects has opened up new perspectives on the highly sophisticated neuroendocrine control mechanisms and the role of neurotransmitters. 2. As a specific prolactin inhibitor, bromocriptine is the treatment of choice in many cases of hyperprolactinemia in female and male. There is ample evidence that with bromocriptine a reduction of pituitary tumor size (particularly in prolactin-secreting tumors) can be achieved. 3. One highly specific use of bromocriptine, and which involves virtually no problems, is inhibition of puerperal lactation. 4. Bromocriptine is effective and useful in the treatment of acromegaly. While it may restore growth hormone levels to normal in mild and selective cases, it may be helpful in controlling severe cases in which surgical or radiotherapeutic approaches have failed to achieve satisfactory results. 5. As a dopamine agonist, bromocriptine offers a new possibility of treating parkinsonism. It may be given alone or, as is preferable in many cases, in combination with submaximal doses of levodopa. 6. Side effects are sometimes only observed on initiation of bromocriptine therapy, sometimes occur only during chronic therapy, and may occasionally necessitate interruption of the treatment. Sometimes continuation of therapy leads to tolerance of unwanted effects. Patients should be informed before the start of bromocriptine treatment about the possibility of side effects. With proper instruction on the manner in which the drug should be taken, many adverse reactions can be avoided or diminished.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M P König. 1981-02-28. [Bromocriptine therapy].. https://pubmed.ncbi.nlm.nih.gov/6111843/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Acquired narcolepsy in an acromegalic patient who underwent pituitary irradiation.

The authors report the case of a 60-year-old man with acromegaly, who developed narcolepsy 2 weeks after completing radiotherapy for a pituitary adenoma. Cataplexy and sleepiness were predominant symptoms. Onset of narcolepsy is unusual at this age and the temporal relationship following radiotherapy suggests this treatment was implicated. His CSF hypocretin levels were normal, indicating other factors may be important in his narcolepsy.

Acromegaly↗

Cavernous carotid artery pseudo-aneurysm treated by stenting in acromegalic patient.

We report on a case of endovascular management of pseudoaneurysm of the cavernous segment of the internal carotid artery with covered stent reconstruction. A 36 years-old woman with a history of previous transsphenoidal approach for pituitary macroadenoma and false aneurysma formation was studied in a protocol that included balloon test occlusion and cerebral blood flow evaluation. An endovascular covered stent deployment in the area of the carotid laceration was performed with isolation of the aneurysm from the circulation and maintenance of the carotid flow. Helical angio-CT and cerebral digital subtraction angiography showed the carotid preservation without stenosis in the stented area. In conclusion, endovascular stent reconstruction for post-transsphenoidal carotid artery laceration and false aneurysm is demonstrated as useful technical adjunct in the management strategy and with the potential for carotid sacrifice morbidity avoidance.

Acromegaly↗